ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VIRI Virios Therapeutics Inc

0.4997
0.016 (3.31%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Virios Therapeutics Inc VIRI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.016 3.31% 0.4997 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.49 0.42 0.53 0.4791 0.4837
more quote information »

Recent News

Date Time Source Heading
3/26/202409:15GLOBEVirios Therapeutics Announces Publication of International..
3/08/202417:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
3/06/202416:30EDGAR2Form 8-K - Current report
3/01/202409:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202409:25EDGAR2Form 8-K - Current report
2/29/202409:15GLOBEVirios Therapeutics Announces Fourth Quarter and Full Year..
2/28/202413:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202413:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202412:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202412:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202412:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202412:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202412:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202412:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202409:15GLOBEVirios Therapeutics Issues Shareholder Letter..
2/27/202416:15EDGAR2Form 8-K - Current report
2/02/202416:31EDGAR2Form DEF 14A - Other definitive proxy statements
1/22/202409:33EDGAR2Form PRE 14A - Other preliminary proxy statements
1/22/202409:00GLOBEVirios Therapeutics Announces Plans to Advance..
1/03/202407:05EDGAR2Form 8-K - Current report
1/02/202407:05GLOBEVirios Therapeutics, Inc. Reaches Alignment with FDA on..
11/13/202309:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202307:20EDGAR2Form 8-K - Current report
11/13/202307:05GLOBEVirios Therapeutics Announces Third Quarter 2023 Financial..
11/07/202307:29EDGAR2Form 8-K - Current report
11/06/202307:05GLOBEVirios Therapeutics to Report Third Quarter 2023 Financial..
11/02/202307:05EDGAR2Form 8-K - Current report
10/12/202307:05GLOBEVirios Therapeutics to Present at the ThinkEquity Conference..
9/18/202307:16EDGAR2Form 8-K - Current report
9/18/202307:05GLOBEVirios Therapeutics Announces Termination of At-The-Market..
9/12/202307:05GLOBEVirios Therapeutics CEO Greg Duncan to Present at the..
8/22/202315:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/18/202307:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202307:05GLOBEVirios Therapeutics Announces Halt to At-The-Market Offering..
8/11/202308:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:15EDGAR2Form 8-K - Current report
8/10/202307:05GLOBEVirios Therapeutics Announces Second Quarter 2023 Financial..
8/09/202307:15EDGAR2Form 8-K - Current report
8/09/202307:05GLOBEVirios Therapeutics Announces Plans to Advance Lead..
8/03/202316:05GLOBEVirios Therapeutics to Report Second Quarter 2023 Financial..
7/17/202307:15EDGAR2Form 8-K - Current report
7/17/202307:05GLOBEVirios Therapeutics Announces Positive Data Demonstrating..
7/14/202316:25EDGAR2Form 8-K - Current report
7/14/202316:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/25/202316:05GLOBEVirios Therapeutics Regains Compliance with Nasdaq Minimum..
5/15/202307:05GLOBEVirios Therapeutics Announces Submission of Final Toxicology..
5/11/202307:05GLOBEVirios Therapeutics Announces First Quarter 2023 Financial..
5/04/202307:05GLOBEVirios Therapeutics to Report First Quarter 2023 Financial..
4/24/202316:15GLOBEVirios Therapeutics Announces Initial FDA Feedback on..

Your Recent History

Delayed Upgrade Clock